New Key Statistics Module, Z-Score and F-Score
NAS:MRSN Key Ratios
| Market Cap $ M | 88.94 |
| Enterprise Value $ M | -34.72 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 80.00 |
| Price/Sales | 2.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 34.00 |
| EPS (TTM) $ | -0.61 |
| Beneish M-Score | -1.31 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -2.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.49 |
| EV-to-EBITDA | 0.51 |
| PEG | -- |
| Shares Outstanding M | 123.53 |
| Net Margin (%) | -214.20 |
| Operating Margin % | -228.07 |
| Pre-tax Margin (%) | -213.00 |
| Quick Ratio | 2.35 |
| Current Ratio | 2.35 |
| ROA % (ttm) | -36.01 |
| ROE % (ttm) | -294.80 |
| ROIC % (ttm) | -167.35 |
| Dividend Yield % | -- |
| Altman Z-Score | -7.47 |
MRSN Number of Guru Trades
MRSN Volume of Guru Trades
Gurus Latest Trades with NAS:MRSN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MRSN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Mersana Therapeutics Inc Insider Transactions
No Available Data
News about NAS:MRSN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers